The VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents. Fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases.
Published June 20, 2018 · Recall initiated: March 23, 2018
Summary
FDA records medical device Class II recall Z-2167-2018, published June 20, 2018 and initiated March 23, 2018. Recalling firm: BioMerieux SA; Status: Terminated; Reported quantity: 5 boxes with AST-P606 TEST KIT 20 CARDS; Lot: VITEK® 2 AST-P606 (ref: 22330): Lot Number 4860117403. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A shipment to Guadeloupe suffered a temperature excursions up to 47.8®C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioM®rieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BioMerieux SA
- Distributor
- International distribution.
- Lot
- VITEK® 2 AST-P606 (ref: 22330): Lot Number 4860117403
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- France
Related recalls
- FDAEMAG system Model/Catalog Number: 418591/418591U Product Description: Nucleic acid sample preparationNovember 4, 2026
- FDAMYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission ofAugust 18, 2021
- FDAVIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux SA, France. For use on theJuly 4, 2018
- FDAPrima Plus ¿4.1 x 11.5mm Implant, Catalog Number 15737K Keystone Dental implants are intended for use inJune 20, 2018
- FDARS 5F DL BIOFLO PASV, Catalog Number 60M132324June 20, 2018
- FDAETEST OXACILLIN OX 256 US F100 In vitro diagnostic, a quantitative technique for determining the antimicrobialDecember 27, 2017
Questions about this recall
Was The VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents. Fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases. recalled?
Yes. FDA published recall Z-2167-2018 on June 20, 2018. Reported hazard: A shipment to Guadeloupe suffered a temperature excursions up to 47.8®C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioM®rieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers.
What should I do if I have this product?
Voluntary: Firm initiated · Letter